Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Court Tosses VirnetX’s $368 Million Patent Judgment Against Apple

The ruling sent VirnetX stock down by almost 50 percent.

Reuters / Yuya Shino

A federal appeals court on Tuesday threw out a jury order requiring Apple to pay VirnetX Holding Corp $368.2 million in damages for infringing four patents concerning technology for providing security over the Internet.

Shares of VirnetX plunged as much as 59.8 percent after the decision by the U.S. Federal Circuit Court of Appeals in Washington. The company and its lawyer did not immediately respond to requests for comment.

Apple had appealed a November 2012 jury finding that it infringed VirnetX’s patents for virtual private network, or VPN, technology through the FaceTime feature on its iPhone, iPod Touch and iPad products, as well as on its Mac computers.

While agreeing that some patents were infringed, the appeals court said the verdict was tainted by incorrect jury instructions from the trial judge on how to calculate damages, and that the error was not harmless.

It also agreed with Apple that testimony from a VirnetX expert over how to determine potential royalties should have been excluded, saying it did not reflect the extent to which the patented features were a factor in product sales.

“The law requires patentees to apportion the royalty down to a reasonable estimate of the value of its claimed technology, or else establish that its patented technology drove demand for the entire product,” Chief Judge Sharon Prost wrote for a two-judge panel. A third judge resigned before the decision was issued.

The appeals court returned the case to the U.S. District Court in Tyler, Texas, for further proceedings.

VirnetX is based in Zephyr Cove, Nev. It was assigned the four patents at issue by Science Applications International in 2006, court papers show.

In May 2010, VirnetX won a $200 million settlement from Microsoft over the VPN technology.

Apple did not immediately respond to a request for comment.

In midday trading, VirnetX shares were down by almost 50 percent.

The case is Apple Inc v VirnetX Inc et al, U.S. Federal Circuit Court of Appeals, No. 2013-1489.

(Reporting by Jonathan Stempel in New York; Additional reporting by Dan Levine in San Francisco; Editing by Jonathan Oatis)

This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh